Sector | Healthcare | Compare with Sector peers |
Industry | Hospital & Healthcare Services | Compare with Industry peers |
Website | http://www.thyrocare.com | |
Market Cap | 3,450.93 Cr. | |
Enterprise Value(EV) | 3,450.08 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 12.39 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 52.61 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 67.02 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 94.59 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 6.89 | Calculated using Price: 651.70 |
Dividend Yield | 2.76 | Period Ending 2023-03 |
No. of Shares Subscribed | 5.30 Cr. | 52,952,676 Shares |
FaceValue | 10 | |
About Thyrocare Technologies Ltd. | ||
Thyrocare Technologies is an India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia. The Company offers technologies, including Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion Selective Electrode (ISE), Fluorescence Flow Cytometry, Nephelometry, Photometry, Liquid Chromatography Mass Spectrometry (LC-MS), Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Cytogenetics. The Company offers cancer diagnosis and water testing through its brands Nueclear and Whaters, respectively. |
1 Day |
|
-0.73% |
1 Week |
|
+6.23% |
1 Month |
|
+7.23% |
3 Month |
|
+4.74% |
6 Month |
|
+26.55% |
1 Year |
|
+46.45% |
2 Year |
|
-19.13% |
5 Year |
|
+30.82% |
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 15.98 | 16.22 | 11.19 | 22.12 | 19.53 | 22.26 | 28.75 | 37.18 | 12.23 | |
Return on Capital Employed (%) | 24.57 | 25.66 | 21.04 | 33.89 | 31.48 | 35.27 | 38.51 | 48.42 | 17.61 | |
Return on Assets (%) | 13.41 | 14.09 | 10.19 | 20.55 | 18.05 | 18.84 | 22.43 | 25.38 | 7.65 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 276 | 366 | 408 | 443 | 435 | 367 | 427 | 527 | 534 | 486 | |
Non Curr. Liab. | 9 | 10 | 9 | 10 | 14 | 21 | 18 | 106 | 149 | 23 | |
Curr. Liab. | 7 | 31 | 18 | 20 | 21 | 82 | 95 | 215 | 151 | 69 | |
Minority Int. | 36 | 1 | 1 | ||||||||
Equity & Liab. | 328 | 407 | 434 | 474 | 470 | 469 | 540 | 848 | 835 | 579 | |
Non Curr. Assets | 218 | 273 | 285 | 332 | 334 | 317 | 300 | 427 | 488 | 370 | |
Curr. Assets | 111 | 134 | 150 | 142 | 117 | 121 | 200 | 421 | 347 | 209 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 328 | 407 | 434 | 474 | 470 | 469 | 540 | 848 | 835 | 579 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 183 | 241 | 304 | 356 | 403 | 434 | 495 | 589 | 527 | 554 | |
Other Income | 8 | 7 | 12 | 23 | 10 | 7 | 12 | 29 | 8 | 10 | |
Total Income | 191 | 248 | 317 | 379 | 413 | 441 | 507 | 618 | 535 | 563 | |
Total Expenditure | -110 | -147 | -189 | -212 | -249 | -261 | -323 | -353 | -404 | -425 | |
PBIDT | 81 | 101 | 128 | 168 | 164 | 180 | 184 | 265 | 131 | 138 | |
Interest | 0 | -1 | 0 | 0 | -1 | -2 | -1 | -3 | -5 | -4 | |
Depreciation | -13 | -18 | -18 | -20 | -26 | -32 | -30 | -34 | -39 | -45 | |
Taxation | -24 | -30 | -39 | -52 | -53 | -52 | -39 | -52 | -24 | -26 | |
Exceptional Items | -27 | -2 | -7 | ||||||||
PAT | 44 | 52 | 43 | 93 | 85 | 88 | 113 | 176 | 64 | 64 | |
Minority Interest | 1 | 1 | |||||||||
Share Associate | 1 | ||||||||||
Other Related Items | 0 | 0 | 0 | 0 | -1 | 0 | 2 | ||||
Consolidated Net Profit | 45 | 52 | 43 | 93 | 85 | 89 | 112 | 176 | 66 | 66 | |
Adjusted EPS | 9 | 10 | 8 | 17 | 16 | 17 | 21 | 33 | 12 | 12 |
Particulars | 9 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 34 | 68 | 90 | 107 | 100 | 168 | 115 | 113 | 129 | |
Cash Fr. Inv. | -18 | -18 | -42 | -43 | -12 | 1 | -49 | -24 | -39 | |
Cash Fr. Finan. | -23 | -45 | -49 | -64 | -94 | -165 | -62 | -89 | -86 | |
Net Change | -6 | 5 | 0 | 0 | -5 | 4 | 4 | 0 | 4 | |
Cash & Cash Eqvt | 5 | 10 | 10 | 10 | 5 | 9 | 13 | 14 | 18 |
Wed, 17 Apr 2024
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent THYROCARE TECHNOLOGIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
Tue, 16 Apr 2024
Updates Thyrocare Technologies Limited has informed the Exchange regarding 'Resignation of Mr Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer of the company w.e.f. April 26, 2024.'. |
Sat, 06 Apr 2024
Updates Thyrocare Technologies Limited has informed the Exchange regarding 'Revised Rectification order passed by the Income Tax Department Mumbai'. |
Fri, 26 Apr 2024 |
Close Within 52 Week High Zone |
High Increase in 1 Month |
High Increase in 6 Months |
High Increase in 1 Year |
CCI Overbought Zone |